Antitrust: Joint statement by the European competition authorities on the coronavirus crisis
Veel uudiseid samal teemal
The Competition Authority conducted an analysis of the competition situation in order to assess the functioning of the regulation that sets the limits for the prices of medicines. The Competition Authority considers that the current system for the mark-up of medicines is deficient and its supervision is fragmented. As a result, there is a significant risk of non-compliance with the set rules.
The Competition Authority recommends setting notary fees not as fixed rates but as an upper threshold (limit prices), notaries then being able to use price lists below that limit and if necessary then to agree more favourable prices with a client. With this the consumer gets the opportunity to choose between notaries offering the same operations for different prices.